KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Goodwill: 2010-2023

Historic Goodwill for Emergent BioSolutions (EBS) over the last 12 years, with Jun 2023 value amounting to $218.2 million.

  • Emergent BioSolutions' Goodwill fell 2.98% to $218.2 million in Q2 2023 from the same period last year, while for Jun 2023 it was $218.2 million, marking a year-over-year decrease of 2.98%. This contributed to the annual value of $218.2 million for FY2022, which is 2.98% down from last year.
  • As of Q2 2023, Emergent BioSolutions' Goodwill stood at $218.2 million, which was down 0.00% from $218.2 million recorded in Q1 2023.
  • Emergent BioSolutions' 5-year Goodwill high stood at $268.6 million for Q3 2019, and its period low was $218.2 million during Q4 2022.
  • Over the past 3 years, Emergent BioSolutions' median Goodwill value was $224.9 million (recorded in 2022), while the average stood at $235.4 million.
  • Its Goodwill has fluctuated over the past 5 years, first surged by 446.71% in 2019, then declined by 15.67% in 2021.
  • Over the past 5 years, Emergent BioSolutions' Goodwill (Quarterly) stood at $266.6 million in 2019, then climbed by 0.04% to $266.7 million in 2020, then fell by 15.67% to $224.9 million in 2021, then dropped by 2.98% to $218.2 million in 2022, then dropped by 2.98% to $218.2 million in 2023.
  • Its Goodwill stands at $218.2 million for Q2 2023, versus $218.2 million for Q1 2023 and $218.2 million for Q4 2022.